Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20142522 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL4260574 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL12791104 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL12791152 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL2322366 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL9398013 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL12791220 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL20746956 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL21126455 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL11262421 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077631-B2 | Bulk polymerisation of polyoxazolidone | BASF SE (DE) | 2024-09-03 | — | — | US | disclosed |
| US-20240216515-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-07-04 | — | — | US | disclosed |
| US-20240216515-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-07-04 | — | — | US | disclosed |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | RECODE THERAPEUTICS, INC. | 2024-07-04 | — | — | US | disclosed |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | RECODE THERAPEUTICS, INC. | 2024-07-04 | — | — | US | disclosed |
| US-20240207178-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-06-27 | — | — | US | disclosed |
| EP-3538575-B1 | HIGH CIS-1,4 BLOCK COPOLYMERS OF POLYBUTADIENE AND POLYISOPRENE | BRIDGESTONE CORP (JP) | 2024-03-13 | — | — | EP | disclosed |
| US-11884767-B2 | High cis-1,4 block copolymers of polybutadiene and polyisoprene | BRIDGESTONE CORPORATION (JP) | 2024-01-30 | — | — | US | disclosed |
| WO-2023215790-A1 | CO-DELIVERY OF INHIBITORY NUCLEIC ACIDS AND GENOME EDITORS FOR TUMOR THERAPY | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-11-09 | — | — | WO | disclosed |
| US-20230302138-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | RECODE THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |
| WO-2006061188-A1 | PURIFICATION OF IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-15 | — | — | WO | disclosed |
| WO-2006056378-A1 | METHOD FOR CHEMICALLY REACTING AND SEPARATING A MIXTURE IN A COLUMN | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-01 | — | — | WO | disclosed |
| WO-2006029884-A1 | METHOD FOR OPERATING A LIQUID RING COMPRESSOR | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-23 | — | — | WO | disclosed |
| WO-2005068404-A1 | DISTILLATION OF IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-28 | — | — | WO | disclosed |
| CN-1622925-A | Method for separating acid from chemical reaction mixture by using ionic liquid | BASF AG (DE) | 2005-06-01 | — | — | CN | disclosed |
| US-20050020857-A1 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
| EP-1472201-A2 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-03 | — | — | EP | disclosed |
| EP-1470136-A1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003062171-A2 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | WO | disclosed |
| WO-2003062251-A1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302138-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | CHMP4B, LIPA, NPC1L1 | DNM1 307/4885THRB 2609/4885TSHR 2262/4885 |
| US-20240207178-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | CHMP4B, LIPA, NPC1L1 | DNM1 307/4885THRB 2609/4885TSHR 2262/4885 |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | LIPA, NPC1L1, NPC1 | DNM1 487/4885THRB 4690/4885TSHR 3323/4885 |
| US-20240216515-A1 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS | PNLIP, LIPA, PHOSPHO1 | DNM1 1488/4885THRB 1435/4885TSHR 2016/4885 |
| US-20050020857-A1 | Removal by salt formation | PHOSPHO1, AASDHPPT, INPP5B | DNM1 2824/4885THRB 1392/4885TSHR 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.